NYSE - Delayed Quote USD

Becton, Dickinson and Company (BDX)

233.15

+0.94

(+0.40%)

At close: April 18 at 4:00 PM EDT

233.83

+0.68

(+0.29%)

After hours: April 18 at 6:58 PM EDT

Should You Hold Becton, Dickinson and Company (BDX)?

Madison Investments, an investment advisor, released its “Madison Investors Fund” first-quarter 2024 investor letter. A copy of the same can be downloaded here. In the first quarter, the fund (Class Y) returned 9.63% compared to a 10.56% return for the S&P 500 index. The business remains dedicated to its more than two-decades-old strategy of investing in […]

Insider Monkey 21 hours ago

BDX
+0.40%
^GSPC
Here's Why You Should Hold BD (BDX) Stock in Your Portfolio

BD's (BDX) slew of product launches and strategic deals raises optimism about the stock.

Zacks 6 days ago

BDX
+0.40%
CAH
-0.49%
LMAT
BD Named a Best Employer for Excellence in Employee Well-Being

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will receive the Business Group on Health "Best Employers: Excellence in Health & Well-being Award" for its commitment to advancing employee well-being through comprehensive and innovative benefits and initiatives.

PR Newswire 9 days ago

BDX
+0.40%
BD's (BDX) Latest Product to Offer Wider Access to Researchers

The latest worldwide commercial availability of BD's (BDX) cell sorters is set to expand researchers' capabilities to transform research and cell-based therapeutic development across numerous fields.

Zacks 10 days ago

BDX
+0.40%
CAH
-0.49%
DVA
BD Increases Access to Cutting-Edge Image-Enabled, Spectral Cell Sorters

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of new cell sorters that will enable more researchers in a broader range of fields, including cell biology, cancer research and immunology, to reveal insights that were previously invisible in traditional flow cytometry experiments.

PR Newswire 13 days ago

BDX
+0.40%
BD to Announce Financial Results for its Second Quarter of Fiscal 2024

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its second quarter of fiscal year 2024 on Thursday, May 2, 2024. A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors, along with related presentation materials. The news release and presentation materials will include summary financial information for the company's second quarter

PR Newswire 14 days ago

BDX
+0.40%
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks 14 days ago

BDX
+0.40%
Rich Returns at a Discount: 3 Dividend Aristocrats Trading at 52-Week Lows

Looking for Dividend aristocrats trading at their 52-week lows? If so, you’ve come to the right place. Investing shouldn’t always be about chasing high-flying stocks. Sometimes, the best picks can be those hiding in plain sight. A contrarian view might give you a once-in-a-decade opportunity to own a top-tier stock. I can’t blame investors for rushing to the exit when stocks are in free fall. However, prudent investors know that downturns can be great opportunities to snag quality stocks at a ba

InvestorPlace 15 days ago

BF-B

BDX
+0.40%
JNJ
BDX vs. MMSI: Which Stock Is the Better Value Option?

BDX vs. MMSI: Which Stock Is the Better Value Option?

Zacks 15 days ago

MMSI

BDX
+0.40%
11 Magnificent Dividend Growth Stocks to Buy and Hold Forever

In this article, we will take a detailed look at the 11 Magnificent Dividend Growth Stocks to Buy and Hold Forever. For a quick overview of such stocks, read our article 5 Magnificent Dividend Growth Stocks to Buy and Hold Forever. Amid eye-popping growth of technology stocks, dividend investing has taken a backseat over the past few months. But this […]

Insider Monkey 16 days ago

TGT

PEP

KO
AngioDynamics (ANGO) Settles Patent Litigations With BD

AngioDynamics (ANGO) announces its settlement agreement with BD's affiliate, C.R. Bard, to resolve a 10-year dispute over outstanding patent litigation.

Zacks 16 days ago

ANGO

CAH
-0.49%
DVA
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks 21 days ago

BDX
+0.40%
New Survey Reveals Patients Receive Too Many Needlesticks

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the results of a new survey conducted by The Harris Poll that reveals that many patients receive too many needlesticks in hospital procedures and amplifies misconceptions and lack of awareness from Americans on the risks of common medical procedures.

PR Newswire 22 days ago

BDX
+0.40%
BD Named Among Fortune's Most Innovative Companies

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2024 list of America's Most Innovative Companies.

PR Newswire 23 days ago

BDX
+0.40%
QIAGEN (QGEN) Partners With IPPA to Raise TB Screening Awareness

QIAGEN's (QGEN) collaboration with IPPA follows the updated CDC guidelines for TB screening for immigrants in the United States.

Zacks 24 days ago

QGEN

TMO

BDX
+0.40%
UPDATE 3-Becton Dickinson ramps up syringe production in US amid China quality concerns

Becton Dickinson said on Thursday it has increased production of medical syringes in the United States after the country's drug regulator recommended not using some China-made syringes as part of its ongoing quality probe. The U.S.-based medical equipment maker — one of the world's largest syringe suppliers — said it had increased manufacturing in its Nebraska and Connecticut facilities, since the U.S. Food and Drug Administration first raised concerns about China-made syringes in November. The FDA had said last year it was looking into reports of leaks, breakages and other quality problems with plastic syringes manufactured in China and that it may prevent such syringes from entering the U.S. market, if necessary.

Reuters 28 days ago

BDX
+0.40%
BD Increases Domestic Production to Support U.S. Health Care Need for Syringes

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the March 19, 2024 U.S. Food and Drug Administration (FDA) Safety Communication, which provided important updates on FDA's ongoing evaluation of certain plastic syringes:

PR Newswire 28 days ago

BDX
+0.40%
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks 30 days ago

BDX
+0.40%
BD and Health Care Consortium in Denmark Find Success in Medical Waste Recycling Study

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and a consortium of health care institutions in Denmark have innovated a method to recycle used blood collection tubes without compromising hygiene, safety or quality of the material.

PR Newswire last month

BDX
+0.40%
BD's (BDX) ADC System Favored by New Study for Long-Term Care

BD's (BDX) ADC system is likely to result in improvements in clinical workflow, operational efficiency and financial savings in long-term care facilities.

Zacks last month

BDX
+0.40%
CAH
-0.49%
DVA

Performance Overview

Return	BDX	S&P 500
YTD	-3.99%	+5.06%
1-Year	-7.64%	+20.71%
3-Year	-4.39%	+19.73%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Becton, Dickinson and Company (BDX)

Should You Hold Becton, Dickinson and Company (BDX)?

Here's Why You Should Hold BD (BDX) Stock in Your Portfolio

BD Named a Best Employer for Excellence in Employee Well-Being

BD's (BDX) Latest Product to Offer Wider Access to Researchers

BD Increases Access to Cutting-Edge Image-Enabled, Spectral Cell Sorters

BD to Announce Financial Results for its Second Quarter of Fiscal 2024

Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term

Rich Returns at a Discount: 3 Dividend Aristocrats Trading at 52-Week Lows

BDX vs. MMSI: Which Stock Is the Better Value Option?

11 Magnificent Dividend Growth Stocks to Buy and Hold Forever

AngioDynamics (ANGO) Settles Patent Litigations With BD

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

New Survey Reveals Patients Receive Too Many Needlesticks

BD Named Among Fortune's Most Innovative Companies

QIAGEN (QGEN) Partners With IPPA to Raise TB Screening Awareness

UPDATE 3-Becton Dickinson ramps up syringe production in US amid China quality concerns

BD Increases Domestic Production to Support U.S. Health Care Need for Syringes

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

BD and Health Care Consortium in Denmark Find Success in Medical Waste Recycling Study

BD's (BDX) ADC System Favored by New Study for Long-Term Care

Performance Overview